Social Media Ideas for Ardx

Latest updates for Ardx

Fresh curated links around ARDX are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Post angles to try

Share the most useful takeaway for your audience.

Turn one article into a quick practical checklist.

Ask your audience how this shift affects their work.

Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source

cafepharma.com /1 month ago

Argenx

Argenx Anonymous (not verified) Sat, 05/30/2026 - 14:41 field_thread_url https://cafepharma.com/boards/threads/argenx.665212/ board name...

Read source

seekingalpha.com /1 week ago

Ardelyx: The Market Is Right To Discount This Revenue Growth

Read source

finance.yahoo.com /3 weeks ago

What’s Fueling Optimism Around Ardelyx, Inc. (ARDX)’s Sales and Pipeline?

Read source

seekingalpha.com /1 month ago

Arcutis Biotherapeutics, Inc. (ARQT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Read source

seekingalpha.com /1 month ago

Arcturus Therapeutics Holdings Inc. (ARCT) Shareholder/Analyst Call Prepared Remarks Transcript

Read source

cafepharma.com /1 month ago

ADC Therapeutics

ADC Therapeutics Anonymous (not verified) Sun, 06/07/2026 - 17:48 field_thread_url https://cafepharma.com/boards/threads/adc-therapeutics.665008/...

Read source

seekingalpha.com /1 month ago

ADC Therapeutics SA (ADCT) Discusses Phase III LOTIS-5 Trial Results and Next Steps in DLBCL - Slideshow

Read source

seekingalpha.com /1 month ago

argenx: The FcRn Franchise Is Becoming An Autoimmune Operating System

Read source

newswire.com /2 weeks ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ARS Pharmaceuticals, Inc. - SPRY

Read source

finance.yahoo.com /3 weeks ago

Here’s Why Armata Pharmaceuticals Inc. (ARMP) is a High Growth Micro-Cap Stock to Buy?

Read source

seekingalpha.com /1 month ago

NRx Pharmaceuticals, Inc. (NRXP) Q1 2026 Earnings Call Transcript

Read source

seekingalpha.com /1 month ago

Applied Aerospace & Defense seeks $3.59 billion valuation in IPO

Read source

seekingalpha.com /1 month ago

Design Therapeutics, Inc. (DSGN) Discusses Data from RESTORE-FA Trial of DT-216P2 for Friedreich Ataxia Transcript

Read source

seekingalpha.com /3 weeks ago

Alkermes: 'Buy' On Avadel Acquisition And Positive NT2 Data With Alixorexton

Read source

fool.com /3 days ago

What This $1.1 Million Insider Sale at Accelerant Means for Investors

Executed under a pre-arranged Rule 10b5-1 plan, the transaction reduces Radke's stake by just 0.28%, leaving him with ~28.6 million shares worth $379 million.

Read source

seekingalpha.com /1 month ago

Array Technologies, Inc. (ARRY) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conferen...

Read source

seekingalpha.com /2 weeks ago

Aramark: Demand Is Strong, And Nexus Is A New Growth Driver

Read source

seekingalpha.com /1 month ago

Nurix Therapeutics, Inc. (NRIX) Discusses Strategic Collaboration for Development and Commercialization of Bexobrutideg...

Read source

biopharmadive.com /1 month ago

Novartis RNA drug acquired in $12B Avidity deal notches a trial win

The data showed that del-brax, an “antisense oligonucleotide conjugate” being tested against a muscle-wasting disease, met its primary endpoint in a Phase 1/2 study.

Read source

fool.com /1 month ago

PDSB Q4 2025 Earnings Call Transcript

Image source: The Motley Fool. DATEWednesday, May 13, 2026 at 8 a.m. ETCALL PARTICIPANTSChief Executive Officer — Frank Bedu-AddoChief Medical Officer — Kirk ShepardChief Financia...

Read source

seekingalpha.com /1 month ago

Cardiff Oncology, Inc. (CRDF) Discusses Updated Phase II CRDF-004 Data on Onvansertib in First-Line RAS-Mutated Metastat...

Read source

seekingalpha.com /1 month ago

Archer Aviation: Transitioning From R&D To Late-Stage Commercialization

Read source

newswire.com /2 weeks ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.